Dickran Kazandjian

FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy

Dickran Kazandjian, Daniel L. Suzman, Gideon M. Blumenthal et al. · The Oncologist · 2016 · 478 citations · Full text

Medicine, Oncology, Pharmacology +12

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

Neha Korde, Mark Roschewski, Adriana Zingone et al. · JAMA Oncology · 2015 · 309 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements

Dickran Kazandjian, Gideon M. Blumenthal, Huanyu Chen et al. · The Oncologist · 2014 · 289 citations · Full text

Medicine, Oncology, Pharmacology +12

Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non–Small Cell Lung Cancer

Dickran Kazandjian, Yutao Gong, Patricia Keegan et al. · JAMA Oncology · 2019 · 255 citations · Full text

Medicine, Immunology, Oncology +17

Noninvasive Urinary Metabolomic Profiling Identifies Diagnostic and Prognostic Markers in Lung Cancer

Ewy A. Mathé, Andrew D. Patterson, Majda Haznadar et al. · Cancer Research · 2014 · 197 citations · Full text

Medicine, Biochemistry, Oncology +15